Original Research
Published on 28 Sep 2023
Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity—lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices
in Infectious Diseases: Epidemiology and Prevention
Frontiers in Public Health
doi 10.3389/fpubh.2023.1245464
- 2,339 views
- 3 citations



